UNIVERSITY OF UTAH

UNIVERSITY OF UTAH logo
🇺🇸United States
Ownership
Private
Established
1850-02-28
Employees
10K
Market Cap
-
Website
http://www.utah.edu
Clinical Trials
Related News

Practice Effects and Amyloid Imaging Using 18F-PIB or Flutemetamol PET and FDG-PET

Phase 2
Completed
Conditions
Alzheimer's Disease
Interventions
Drug: 18F-Flutemetamol
First Posted Date
2010-09-16
Last Posted Date
2023-05-09
Lead Sponsor
University of Utah
Target Recruit Count
27
Registration Number
NCT01202994
Locations
🇺🇸

University of Utah Center for Alzheimer's Care, Imaging and Research, Salt Lake City, Utah, United States

Genetic Factors Affecting Risks for Rotator Cuff Disease

First Posted Date
2010-09-02
Last Posted Date
2024-05-09
Lead Sponsor
University of Utah
Target Recruit Count
400
Registration Number
NCT01193647
Locations
🇺🇸

VA Salt Lake City, Salt Lake City, Utah, United States

🇺🇸

University of Utah Orthopaedic Center, Salt Lake City, Utah, United States

Discovering the Gene(s) Causing Developmental Dysplasia of the Hip (DDH)

Completed
Conditions
Hip Dysplasia
First Posted Date
2010-09-02
Last Posted Date
2019-10-23
Lead Sponsor
University of Utah
Target Recruit Count
160
Registration Number
NCT01193673
Locations
🇺🇸

University of Utah Orthopaedic Center, Salt Lake City, Utah, United States

Effect of Structural Remodeling on Scar Formation as Assessed by DE-MRI of the Left Atrium

Completed
Conditions
Atrial Fibrillation
First Posted Date
2010-08-24
Last Posted Date
2012-02-13
Lead Sponsor
University of Utah
Target Recruit Count
40
Registration Number
NCT01187914

A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients

First Posted Date
2010-08-24
Last Posted Date
2016-06-17
Lead Sponsor
University of Utah
Target Recruit Count
92
Registration Number
NCT01187901
Locations
🇺🇸

Huntsman Cancer Institute, Salt Lake City, Utah, United States

SOAR: Study Observing Antiarrhythmic Remodelling Using LGE-MRI

Phase 3
Completed
Conditions
Atrial Fibrillation
Interventions
Drug: Placebo
Drug: dronedarone
First Posted Date
2010-08-16
Last Posted Date
2016-02-19
Lead Sponsor
University of Utah
Target Recruit Count
33
Registration Number
NCT01182376

Effects of Lovaza on High Density Lipoprotein (HDL) Composition and Function in Hypertriglyceridemia

First Posted Date
2010-08-12
Last Posted Date
2016-02-08
Lead Sponsor
University of Utah
Registration Number
NCT01180764
Locations
🇺🇸

University of Utah, Salt Lake City, Utah, United States

Creatine Augmentation in Veterans With SSRI-Resistant Major Depression

Phase 4
Withdrawn
Conditions
Major Depressive Disorder
Interventions
Drug: Creatine
First Posted Date
2010-08-05
Last Posted Date
2016-08-15
Lead Sponsor
University of Utah
Registration Number
NCT01175616

Fentanyl vs. Low-Dose Ketamine for the Relief of Moderate to Severe Pain in Aeromedical Patients

Not Applicable
Withdrawn
Conditions
Trauma
Pain
Interventions
Drug: Fentanyl
Drug: Ketamine
First Posted Date
2010-07-23
Last Posted Date
2012-06-04
Lead Sponsor
University of Utah
Registration Number
NCT01169025
Locations
🇺🇸

University of Utah Medical Center, Salt Lake City, Utah, United States

Inflammatory Cytokine Quantification in Infants

First Posted Date
2010-07-02
Last Posted Date
2015-05-04
Lead Sponsor
University of Utah
Target Recruit Count
21
Registration Number
NCT01155830
Locations
🇺🇸

Primary Children's Medical Center, Salt Lake City, Utah, United States

🇺🇸

University of Utah, Salt Lake City, Utah, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy